13.14
Precedente Chiudi:
$13.15
Aprire:
$13.25
Volume 24 ore:
102.46K
Relative Volume:
1.67
Capitalizzazione di mercato:
$245.78M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-0.4386
EPS:
-29.96
Flusso di cassa netto:
-
1 W Prestazione:
+0.61%
1M Prestazione:
+942.94%
6M Prestazione:
+942.94%
1 anno Prestazione:
+942.94%
Shoulder Innovations Inc Stock (SI) Company Profile
Nome
Shoulder Innovations Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta SI con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
SI
Shoulder Innovations Inc
|
13.14 | 245.78M | 0 | 0 | 0 | 0.00 |
![]()
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-03-06 | Downgrade | Compass Point | Neutral → Sell |
2023-03-06 | Downgrade | Wedbush | Neutral → Underperform |
2023-03-02 | Downgrade | Canaccord Genuity | Buy → Hold |
2023-03-02 | Downgrade | Compass Point | Buy → Neutral |
2023-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
2023-03-01 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
2023-01-09 | Downgrade | Wedbush | Outperform → Neutral |
2023-01-06 | Downgrade | BofA Securities | Neutral → Underperform |
2023-01-06 | Downgrade | Craig Hallum | Buy → Hold |
2023-01-06 | Downgrade | JP Morgan | Overweight → Neutral |
2022-12-12 | Reiterato | Wedbush | Outperform |
2022-12-05 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
2022-11-21 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
2022-11-10 | Downgrade | BofA Securities | Buy → Neutral |
2022-10-26 | Downgrade | Goldman | Buy → Neutral |
2022-10-06 | Downgrade | Wells Fargo | Overweight → Underweight |
2022-08-04 | Iniziato | BTIG Research | Buy |
2022-06-13 | Iniziato | Wells Fargo | Overweight |
2022-06-09 | Ripresa | Morgan Stanley | Equal-Weight |
2022-03-21 | Iniziato | BofA Securities | Buy |
2022-01-20 | Aggiornamento | Goldman | Neutral → Buy |
2021-12-16 | Iniziato | B. Riley Securities | Buy |
2021-11-11 | Iniziato | JP Morgan | Overweight |
2021-11-08 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
2021-09-27 | Iniziato | Morgan Stanley | Overweight |
2021-06-14 | Iniziato | Goldman | Neutral |
2021-01-14 | Downgrade | Barclays | Overweight → Equal Weight |
2020-12-22 | Iniziato | Wedbush | Outperform |
2020-12-17 | Aggiornamento | Keefe Bruyette | Mkt Perform → Outperform |
2020-12-02 | Iniziato | Craig Hallum | Buy |
2020-10-16 | Iniziato | Compass Point | Buy |
2020-03-16 | Iniziato | Canaccord Genuity | Buy |
2019-12-03 | Iniziato | Keefe Bruyette | Mkt Perform |
2019-12-02 | Iniziato | Barclays | Overweight |
2019-11-18 | Iniziato | Compass Point | Buy |
Mostra tutto
Shoulder Innovations Inc Borsa (SI) Ultime notizie
Shoulder Innovations Expands Surgical Solutions with NYSE Listing—Global Brain Invests - thebridge.jp
Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech
Medical Tech Firm Heartflow Jumps 51% After $317 Million IPO - Bloomberg.com
Medical Tech Firm Heartflow Surges 66% After $317 Million IPO - Bloomberg.com
Heartflow raises USD 317M in IPO - Medical Buyer
Medical Tech Firm Heartflow Prices $317 Million IPO Above Range - Bloomberg.com
Shoulder Innovations Stock Jumps 8% On NYSE Debut - MSN
Medical Tech Firm Heartflow Raises IPO Target to $300 Million - Bloomberg.com
Gilde healthcare buys $1.5 million in shoulder innovations (SI) By Investing.com - Investing.com Australia
Gilde healthcare buys $1.5 million in shoulder innovations (SI) - Investing.com
U.S. IPO Weekly Recap: Figma Smashes Circle’s Record For Best Billion-Dollar IPO Pop - Seeking Alpha
Heartflow prices IPO, Shoulder Innovation joins NYSE - BioWorld MedTech
Shoulder Innovations: Interesting, Not Convinced (NYSE:SI) - Seeking Alpha
Shoulder Innovations falls short of IPO target with $75M raise - Crain's Grand Rapids Business
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO - The Malaysian Reserve
Latham & Watkins Advises Shoulder Innovations in Initial Public Offering - Latham & Watkins LLP
Shoulder Innovations announces pricing of IPO - Medical Buyer
Figma Surges in IPO, Valued at Over $19 Billion - AInvest
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO – Company Announcement - Financial Times
Shoulder Innovations Announces Pricing of Initial Public Offering - PR Newswire
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - MSN
Shoulder Innovations is an IPO to watch, this analyst says - Cantech Letter
Grand Rapids device maker plans $105M IPO as implant sales surge - Crain's Grand Rapids Business
Del. Judge Denies $89M Claim In Silvergate Ch. 11 - Law360
US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest
Shoulder Innovations, Inc. (SI): Small MedTech Implant Company Gaining IPO Interest - Smartkarma
These innovations are transforming shoulder replacement surgery for optimal recovery. - thegazette.com
SHOULDER INNOVATIONS, INC. Plans $100 Million IPO for July 31st (SI) - Defense World
Pro Deals: 👩⚕️ Health Tech weekly - Axios
Shoulder Innovations Primes $100M IPO Amid Medtech Surge - Law360
Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO - Smartkarma
Shoulder Innovations Seeks $105M in U.S. IPO, Revenue Up 40% - AInvest
Shoulder Innovations Files for 5M Share IPO at $19-$21/sh - Investing.com Canada
Shoulder Innovations Announces Closing of a $40 Million Convertible Notes Financing - PR Newswire
Shoulder Innovations IPO Preview: Seeing Value In InSet Glenoid Technology and Disruptive Ecosystem - Smartkarma
Silvergate Capital (NYSE:SI) Trading Up 25% – Still a Buy? - Defense World
SEC Charges Alan Lane & Kathleen Fraher - stl.news
U.S. IPO Weekly Recap: 6 Small Listings Hit Market As Sizable IPOs Join The Pipeline - Seeking Alpha
Shoulder Innovations Begins IPO Effort For Commercialization Plans (Pending:SI) - Seeking Alpha
Cohen Milstein Sellers & Toll PLLC and Bernstein Litowitz Berger & Grossmann LLP Announce Pendency and Proposed Settlement of Class Action Involving All Persons and Entities who Purchased or Otherwise Acquired the Publicly Traded Common Stock a - ETX View
Venture-Backed MedTech Firm Shoulder Innovations Files IPO - Law360
SI IPO NewsShoulder surgery-focused medtech Shoulder Innovations files for a $100 million IPO - renaissancecapital.com
Silvergate Announces Virtual Participation at Canaccord’s 40th Annual Growth Conference - Business Wire
Bioretec Oy's Oversubscribed Rights Issue Fuels Ambitious Growth in Orthopedic Innovations - AInvest
Silvergate Capital $37.5M Securities Class Action Settlement - Claim Depot
Head to Head Contrast: Silvergate Capital (NYSE:SI) and RBB Bancorp (NASDAQ:RBB) - Defense World
Fed board issues order to Silvergate Bank as part of self-liquidation plan - PANews
Silvergate Estate To Chip In For $37.5M Investor Settlement - Law360
Head-To-Head Survey: Silvergate Capital (NYSE:SI) & Citizens & Northern (NASDAQ:CZNC) - Defense World
Variability in ultimate humeral height of an inlay humeral stem does not impact outcomes following reverse shoulder arthroplasty - ScienceDirect.com
Silvergate Gets Pause To Examiner Fight After Investor Deal - Law360
Shoulder Innovations Inc Azioni (SI) Dati Finanziari
Non sono disponibili dati finanziari per Shoulder Innovations Inc (SI). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):